Relevance of the study of oligoclonal bands as a prognostic factor of the conversion of clinically isolated syndrome into clinically definite multiple sclerosis in daily practice

被引：0
|
作者：
Dionet, Elsa [1 ]
Taithe, Frederic [1 ]
Lauxerois, Michel [1 ]
Fogli, Anne [1 ]
Clavelou, Pierre [1 ]
机构：
[1] G Montpied Hosp, Dept Neurol, Clermont Ferrand, France
来源：
MULTIPLE SCLEROSIS | 2008年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S119 / S119
页数：1
相关论文
共 50 条
  • [21] Conversion to definite multiple sclerosis in Turkish patients with clinically isolated syndromes
    Mutlu, M.
    Akman-Demir, G.
    Kurtuncu, M.
    Eraksoy, M.
    MULTIPLE SCLEROSIS, 2006, 12 : S167 - S168
  • [22] Treatment with glatiramer acetate delays conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome suggestive of MS
    Comi, G.
    Filippi, M.
    JOURNAL OF NEUROLOGY, 2008, 255 : 10 - 10
  • [23] Retinal Nerve Fiber Layer Thickness As Prognostic Indicator For The Conversion To Clinically Definite Multiple Sclerosis In Clinically Isolated Syndrome With Acute Retrobulbar Optic Neuritis
    Giambene, Barbara
    Di Tullio, Matteo Grammatico
    Massacesi, Luca
    Menchini, Ugo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [24] Smoking is a risk factor for early conversion to clinically definite multiple sclerosis
    Di Pauli, F.
    Reindl, M.
    Ehling, R.
    Schautzer, F.
    Gneiss, C.
    Lutterotti, A.
    O'Reilly, E. J.
    Munger, K. L.
    Deisenhammer, F.
    Ascherio, A.
    Berger, T.
    MULTIPLE SCLEROSIS JOURNAL, 2008, 14 (08) : 1026 - 1030
  • [25] CSF proteome analysis in clinically isolated syndrome: candidate markers for conversion to definite multiple sclerosis
    Tumani, H.
    Lehmensiek, V.
    Rau, D.
    Guttmann, I.
    Tauscher, G.
    Sapunova-Meier, I.
    Mogel, H.
    Ludolph, A.
    Brettschneider, J.
    JOURNAL OF NEUROLOGY, 2009, 256 : S35 - S35
  • [26] CSF Proteome Analysis in Clinically Isolated Syndrome (CIS): Biomarkers for Conversion to Definite Multiple Sclerosis
    Tumani, Hayrettin
    Lehmensiek, Vera
    Rau, Daniela
    Guttmann, Ivonne
    Palm, Christian
    Suessmuth, Sigurd D.
    Brettschneider, Johannes
    NEUROLOGY, 2009, 72 (11) : A197 - A197
  • [27] MRI indices as predictors of clinically definite multiple sclerosis development in patients with a clinically isolated syndrome
    Myalovitska, O.
    Nour, S. Sepehri
    Lobanova, I.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 168 - 168
  • [28] Cerebrospinal fluid oligoclonal bands and/or an elevated IgG index does not increase the risk of clinically definite multiple sclerosis in clinically isolated syndrome patients with brain magnetic resonance imaging lesions
    Smrtka, Jennifer
    Riley, Claire
    Wang, Shuang
    Tullman, Mark J.
    MULTIPLE SCLEROSIS, 2008, 14 : S290 - S290
  • [29] Comparison of two methods for the detection of oligoclonal bands in a large number of clinically isolated syndrome and multiple sclerosis patients
    Andlovic, Aljosa
    Babic, Masa
    Accetto, Slavko
    Rot, Uros
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2012, 114 (06) : 659 - 662
  • [30] CSF proteome analysis in clinically isolated syndrome (CIS): Candidate markers for conversion to definite multiple sclerosis
    Tumani, H.
    Lehmensiek, V.
    Rau, D.
    Guttmann, I.
    Tauscher, G.
    Mogel, H.
    Palm, C.
    Hirt, V.
    Suessmuth, S. D.
    Sapunova-Meier, I.
    Ludolph, A. C.
    Brettschneider, J.
    NEUROSCIENCE LETTERS, 2009, 452 (02) : 214 - 217
12345